PriceTargets.com logo

Aedifica NV/SA - AEDFF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$62.00 As of 04/24/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for AEDFF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aedifica NV/SA Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AEDFF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AEDFF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Aedifica NV/SA in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $62.00.

This chart shows the closing price for AEDFF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Aedifica NV/SA. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/24/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight
11/23/2022HSBCInitiated CoverageBuy
7/5/2022BarclaysLower Target€93.00 ➝ €74.00
6/17/2022Societe GeneraleLower Target€141.50 ➝ €132.50
3/28/2022Morgan StanleyBoost TargetOverweight ➝ Overweight€120.00 ➝ €125.00
3/23/2022UBS GroupInitiated CoverageBuy
11/23/2021Societe GeneraleUpgradeHold ➝ Buy
11/17/2021CitigroupInitiated CoverageBuy
10/12/2021Berenberg BankReiterated RatingBuy
8/16/2021BarclaysReiterated RatingUnderweight
3/3/2021BarclaysReiterated RatingUnderweight
(Data available from 4/25/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/27/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Aedifica NV/SA logo
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in elderly care. Aedifica has developed a portfolio of approx. 620 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Sweden, Ireland and Spain, worth more than 5.8 billion. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following ticker symbols: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been part of the BEL 20, Euronext Brussels' leading share index. Moreover, since 2023, Aedifica has been part of the BEL ESG, the index tracking companies that perform best on ESG criteria. Aedifica is also included in the EPRA, Stoxx Europe 600 and GPR indices. Aedifica's market capitalisation was approx. 2.6 billion as at 20 February 2024.
Read More

Today's Range

Now: $62.00
Low: $62.00
High: $62.00

50 Day Range

MA: $61.25
Low: $56.80
High: $64.08

52 Week Range

Now: $62.00
Low: $56.00
High: $68.00

Volume

N/A

Average Volume

250 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Aedifica NV/SA?

The following sell-side analysts have issued reports on Aedifica NV/SA in the last year:
View the latest analyst ratings for AEDFF.

What is the current price target for Aedifica NV/SA?

0 Wall Street analysts have set twelve-month price targets for Aedifica NV/SA in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Aedifica NV/SA in the next year.
View the latest price targets for AEDFF.

What is the current consensus analyst rating for Aedifica NV/SA?

Aedifica NV/SA currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AEDFF.

What other companies compete with Aedifica NV/SA?

Other companies that are similar to Aedifica NV/SA include Assura, Healthcare Trust, Healthcare Trust, NorthWest Healthcare Properties Real Estate Investment Trust and Primary Health Properties. Learn More about companies similar to Aedifica NV/SA.

How do I contact Aedifica NV/SA's investor relations team?

Aedifica NV/SA's physical mailing address is Rue Belliard 40, Brussels, Brussels Region. The company's listed phone number is 32 2 626 07 70. The official website for Aedifica NV/SA is www.aedifica.be. Learn More about contacing Aedifica NV/SA investor relations.